Literature DB >> 3204680

A histopathologic study on 1,095 surgically resected thyroid specimens.

S H Park1, E H Suh, J G Chi.   

Abstract

A histopathologic study was made on 1,095 thyroid specimens which had been removed surgically under various diagnoses at Seoul National University Hospital during the six-year period, 1976-1981. Among the 1,095 surgically removed thyroids, adenomatous goiter was the most common single disease, accounting for 43% of all cases; this was followed by papillary carcinoma and follicular adenoma. Of the malignant tumors, papillary carcinoma was the most frequent, accounting for 259 cases, 76.85% of all malignancies. Ground glass nuclei and psammoma bodies were seen in approximately 64% and 65% of the papillary carcinomas, respectively. Squamous metaplasia was, however, present in 17%. There were also 53 follicular, 13 anaplastic and seven medullary carcinomas. Of the 56 occult sclerosing carcinomas, most were detected in the backgrounds of the adenomatous goiters. Occult sclerosing carcinoma was found in 9.2% of the adenomatous goiters and in 4.3% of the follicular adenomas.

Entities:  

Mesh:

Year:  1988        PMID: 3204680

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Images in endocrine pathology: psammomatoid calcifications in oncocytic neoplasms of the thyroid, a potential pitfall for papillary carcinoma.

Authors:  Marc P Pusztaszeri; Peter M Sadow; William C Faquin
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

2.  Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Authors:  Anna M Sawka; Sharon Straus; James D Brierley; Richard W Tsang; Lorne Rotstein; Gary Rodin; Amiram Gafni; Shereen Ezzat; Lehana Thabane; Kevin E Thorpe; David P Goldstein
Journal:  Trials       Date:  2010-07-26       Impact factor: 2.279

Review 3.  Do benign thyroid nodules have malignant potential? An evidence-based review.

Authors:  Nimmi Arora; Theresa Scognamiglio; Baixin Zhu; Thomas J Fahey
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

4.  How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Authors:  A M Sawka; S Straus; A Gafni; J D Brierley; R W Tsang; L Rotstein; S Ezzat; L Thabane; G Rodin; S Meiyappan; D David; D P Goldstein
Journal:  Clin Endocrinol (Oxf)       Date:  2011-04       Impact factor: 3.478

5.  Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules.

Authors:  Stella Bernardi; Chiara Dobrinja; Bruno Fabris; Gabriele Bazzocchi; Nicoletta Sabato; Veronica Ulcigrai; Massimo Giacca; Enrica Barro; Nicolò De Manzini; Fulvio Stacul
Journal:  Int J Endocrinol       Date:  2014-06-22       Impact factor: 3.257

6.  The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Authors:  Anna M Sawka; David P Goldstein; James D Brierley; Richard W Tsang; Lorne Rotstein; Shereen Ezzat; Sharon Straus; Susan R George; Susan Abbey; Gary Rodin; Mary Ann O'Brien; Amiram Gafni; Lehana Thabane; Jeannette Goguen; Asima Naeem; Lilian Magalhaes
Journal:  PLoS One       Date:  2009-01-14       Impact factor: 3.240

7.  Secondary Salivary Gland Malignancy in Thyroid Cancer: A United States Population Based Study.

Authors:  Eliza Sharma; Suyash Dahal; Pratibha Sharma; Abani Bhandari; Vishal Gupta; Sumit Dahal
Journal:  J Clin Med Res       Date:  2018-06-04

Review 8.  Molecular Aspects of Thyroid Calcification.

Authors:  Luciana Bueno Ferreira; Etel Gimba; João Vinagre; Manuel Sobrinho-Simões; Paula Soares
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.